Search
Innate Pharma SA
IPHAAdd to Watchlist
1.480USD
-0.040-2.63%
Close 10-07 16:00（ET）
165.32MMarket Cap
LossP/E TTM
Innate Pharma SA (IPHA) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Innate Pharma SA in the past month.
Buy
1 Strong Buy
1 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
7.129USD+357.00%
IPHA Analyst Recommendation Trends
In the current month, IPHA has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. IPHA average Analyst price target in the last month is 7.129.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
4
4
4
4
4
4
FAQs
What is Innate Pharma SA's price target?
Analysts forecast that Innate Pharma SA's price target is USD 6.00, with the highest forecast at USD 11.00 and the lowest forecast at USD 2.00.
What is the analyst rating for Innate Pharma SA?
Based on the ratings of Innate Pharma SA's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.